top glp-1 medications for weight loss 2025 Market Overview: Agonists and the Obesity Market | Blog GLP-1 Medications for Weight Loss:

Highly recommended

FDA approves Ozempic (semaglutide) as the only GLP-1 RA to reduce the risk of worsening kidney disease and cardiovascular death in adults with type 2 diabetes and chronic kidney disease [press release]

Compare this to the indefinite treatment paradigm of pharmaceutical GLP-1 medications, where the expectation is continuous use and discontinuation typically leads to rebound

A recent report from the health policy nonprofit KFF found that across age groups, GLP-1 use is highest among people between the ages of 50 and 64

More serious safety concerns include pancreatitis, gallbladder disease, and a potential risk of diabetic retinopathy complications with semaglutide

included in some trendy products but not widely used yet